Thus, these data indicate that CENPI is an E2F1 target gene and strongly suggest that CENPI overexpression is widespread in breast cancer primarily due to frequent Rb pathway defects, while CENPI allelic copy number aberrations contribute less substantially (Figure 3G). This evidence concerns the gene RB1 and breast carcinoma.